Biology adapted treatment of acute myeloid leukemia

By  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 49-49

Maney Publishing

Access to resources Recommend Favorite

High-dose chemotherapy and autologous stem cell rescue for acute myeloid leukemia remains a safe, effective, and valid option

By Hwang Y.K.W.   Goh Y.T.   Linn Y.C.   Tan C.H.   Tan H.C.P.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2464-2466

Elsevier

Access to resources Recommend Favorite

Non-treatment-related chronic myeloid leukemia as a second malignancy

By Specchia G.   Buquicchio C.   Albano F.   Liso A.   Pannunzio A.   Mestice A.   Rizzi R.   Pastore D.   Liso V.  

Leukemia Research, Vol. 28, Iss. 2, 2004-02 ,pp. : 115-119

Elsevier

Access to resources Recommend Favorite

Genetic biomarkers in acute myeloid leukemia: will the promise of improving treatment outcomes be realized?

By Yang Jay   Schiffer Charles A  

Expert Review of Hematology, Vol. 5, Iss. 4, 2012-08 ,pp. : 395-407

Informa Healthcare

Access to resources Recommend Favorite

Identification of new markers discriminating between myeloid and lymphoid acute leukemia

By Haouas Houda   Haouas Samira   Uzan Georges   Hafsia Aïcha  

Hematology, Vol. 15, Iss. 4, 2010-08 ,pp. : 193-203

Maney Publishing

Access to resources Recommend Favorite